How often does Maxcyte move more than the options market prices?

0 of the last 6 reports moved at least as far as the implied move.

MXCTNasdaqServices-Commercial Physical & Biological Research

Maxcyte, Inc. (MXCT) earnings date, market-implied expected move, and options open interest by expiry

1.39

Pre-market16:00 ETdelayed

Open1.45Volume855,965Mkt cap$143.5MEPS-0.32

Day1.37 – 1.4522%52-wk0.64 – 1.8164%

MXCT

Maxcyte, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 11

after close · in 6 days

est.Q3 FY26

Calendar

Next report

Last report

+9.45%

vs ±81.8% implied · ×0.12

shaded = implied · ▲▼ = realized

Aug 12 '26 · confirmed

Implied vs realized

Linked news

1dDTIL · customerPrecision BioSciences posts Q3 net loss of $7,586 thousand; cash $108,034 thousand
63dTGTX · customerTG Therapeutics to Participate in the Cantor Global Healthcare Conference

News

Largest filed tie

13F top-10 QoQ

−9.13%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

122 managers

Top fund weight

0.00%

MXCT weight · VTI

N-PORTJun 30 '26

1 fund

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Maxcyte (MXCT) is expected to report on Nov 11 after close (estimated date).

Implied vs realized

8 reports

0 of 6≥ implied

avg implied: ±64.1%
avg realized: ±13.8%

Mar 11 '25Mar 11 '25confirmed—▼−8.36%—

May 7 '25May 7 '25confirmed±44.9%▼−11.31%×0.25

Aug 6 '25Aug 6 '25confirmed±37.5%▼−29.90%×0.80

Q3 FY25Nov 12 '25confirmed±64.6%▼−4.43%×0.07

Jan 12 '26Jan 12 '26confirmed±65.8%▼−3.68%×0.06

Q1 FY26Mar 24 '26confirmed—▼−6.81%—

May 12 '26May 12 '26confirmed±90.0%▲+24.06%×0.27

Q2 FY26Aug 12 '26confirmed±81.8%▲+9.45%×0.12

quarterimplied−90%0+90%realized×

Q2 FY26±81.8%▲+9.45%×0.12

May '26±90.0%▲+24.06%×0.27

Q1 FY26—▼−6.81%—

Jan '26±65.8%▼−3.68%×0.06

Q3 FY25±64.6%▼−4.43%×0.07

Aug '25±37.5%▼−29.90%×0.80

2 older reports

May '25±44.9%▼−11.31%×0.25

Mar '25—▼−8.36%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 1 expiry · Nov 4 close

0.00OI · 1 expiry · Nov 4 closeP/C open interest · Jan 15 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

0—Jan 1571d1840%

ExpiryPutsCallsP/C

Jan 1571d0—1840%0.00

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−122.05%as filednet margin · revenue −24.66% QoQ · −14.53% YoY

Revenue$7M−24.66%

Gross profit$6M76.96%−30.76%

Operating income−$10M−140.72%−65.43%

Pre-tax income−$9M−86.82%

Net income−$9M−122.05%−86.82%

Cost of revenue$2M+6.76%

Operating expenses$16M+10.94%

Tax$0—

Other income$1M−5.37%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

PPI ×2.32· ±6.9% vs ±3.0% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±6.9%4 of 10×2.32

CPROFcorporate profits±3.8%7 of 12×1.28

NFPjobs report±3.7%2 of 10×1.26

GDPgross domestic product±3.5%9 of 19×1.17

PCEpersonal income & outlays±3.5%7 of 19×1.17

FOMCrate decision±3.4%9 of 24×1.14

CPIconsumer prices±2.6%6 of 10×0.88

Bar = avg |move| to ±7% · tick = ±3.0% avg day · ×base = |move| ÷ ±3.0% · min 6 releases

Earnings history

EPS -0.08 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 12 '26 · confirmed	-0.08	—
Q1 FY26	Mar 24 '26 · confirmed	-0.04	—
Q3 FY25	Nov 12 '25 · confirmed	-0.12	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod